Value Bridge — MILLS PENINSULA MEDICAL CENTER
Current $26M → Target $42M (+$15.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$26.1M
Current EBITDA
$41.7M
Target EBITDA
+$15.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.5M
Payer Mix Optimization
$8.5M
Cost to Collect Reduction
$2.8M
Clean Claim Improvement
$2.1M
Volume & Rate Growth
$14.1M
What This Means
The 7-lever model projects a 60% EBITDA uplift from $26M to $42M. The highest-impact lever is Volume & Rate Growth at $5.6M probability-weighted.
IC talking point: "We see $16M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $171M in equity value creation."